Company / Interest Expense
CVS Health Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.5B
FY2023
5-year range
$2.3B / $3.0B
FY2019-FY2023
Trend
+9.4%
vs FY2022
Sector context
#2 of 46
Health Care
What the data says
Among 46 Health Care companies, CVS Health is in the bottom 4% for interest expense. Interest Expense has fluctuated over the past 8 years, ranging from $1.1B in FY2017 to $3.0B in FY2021.
Based on SEC 10-K filings.
$2.5B in FY2023 with a 5-year CAGR of -0.9%. Ranks 2nd among 46 companies in Health Care.
Improved from $3.0B to $2.5B over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.5%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 46This company $2.5B Sector average $293.8M
▼
+752.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.9%, indicating a declining trend.
- In FY2023, interest expense increased 9.4% year-over-year.
- Ranks #2 out of 46 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.5B | +9.4% |
| FY2022 | $2.3B | -24.6% |
| FY2021 | $3.0B | +15.9% |
| FY2020 | $2.6B | -13.7% |
| FY2019 | $3.0B | +15.9% |
| FY2018 | $2.6B | +146.6% |
| FY2017 | $1.1B | -1.5% |
| FY2016 | $1.1B | +25.5% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026